Orchestra BioMed Holdings Inc. Dividends
The next dividend date for Orchestra BioMed Holdings Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Orchestra BioMed Holdings Inc. (OBIO)
More About Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Owning Orchestra BioMed Holdings Inc. Stock on the Dividend Date
If you own Orchestra BioMed Holdings Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Orchestra BioMed Holdings Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Orchestra BioMed Holdings Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Orchestra BioMed Holdings Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Orchestra BioMed Holdings Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Orchestra BioMed Holdings Inc. Dividends
You can contact us any time if you would like to ask questions about Orchestra BioMed Holdings Inc. dividends or anything else related to the stock market.